Patients with rheumatoid arthritis (RA) face heightened risks for COVID-19 infection, hospitalization, and mortality, according to results of a systematic review and meta-analysis published in BMC ...
A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback